Recommendations for the management of patients with acute myeloid leukaemia (AML) during the COVID-19 outbreak
March 2020
This guidance identifies treatment strategies in adults with newly diagnosed AML which reduce NHS pressure whilst preserving patient outcomes. Mindful of the pace of change these recommendations will undergo regular review and should be considered valid until 5 April 2020.